American International Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,750
| Closed | -$27.4K | – | 1807 |
|
|
2024
Q1 | $27.4K | Sell |
1,750
-25
| -1% | -$368 | ﹤0.01% | 2893 |
|
|
2023
Q4 | $26.5K | Sell |
1,775
-49
| -3% | -$656 | ﹤0.01% | 2937 |
|
|
2023
Q3 | $29.5K | Sell |
1,824
-126
| -6% | -$3.63K | ﹤0.01% | 2932 |
|
|
2023
Q2 | $80.9K | Buy |
1,950
+413
| +27% | +$25.6K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $92.4K | Sell |
1,537
-45
| -3% | -$3.6K | ﹤0.01% | 2495 |
|
|
2022
Q4 | $116K | Sell |
1,582
-36
| -2% | -$2.71K | ﹤0.01% | 2435 |
|
|
2022
Q3 | $123K | Buy |
1,618
+5
| +0.3% | +$390 | ﹤0.01% | 2436 |
|
|
2022
Q2 | $112K | Sell |
1,613
-331
| -17% | -$24.9K | ﹤0.01% | 2534 |
|
|
2022
Q1 | $161K | Buy |
1,944
+1
| +0.1% | +$74 | ﹤0.01% | 2373 |
|
|
2021
Q4 | $146K | Sell |
1,943
-67
| -3% | -$6.72K | ﹤0.01% | 2545 |
|
|
2021
Q3 | $234K | Sell |
2,010
-153
| -7% | -$23.1K | ﹤0.01% | 2341 |
|
|
2021
Q2 | $480 | Sell |
2,163
-96
| -4% | -$18.7K | ﹤0.01% | 1953 |
|
|
2021
Q1 | $299 | Sell |
2,259
-271
| -11% | -$42.9K | ﹤0.01% | 2141 |
|
|
2020
Q4 | $438 | Sell |
2,530
-70
| -3% | -$9.58K | ﹤0.01% | 1828 |
|
|
2020
Q3 | $289K | Sell |
2,600
-119
| -4% | -$9.52K | ﹤0.01% | 1912 |
|
|
2020
Q2 | $161K | Sell |
2,719
-48,709
| -95% | -$3.2M | ﹤0.01% | 2255 |
|
|
2020
Q1 | $3.46M | Sell |
51,428
-2,972
| -5% | -$235K | 0.02% | 717 |
|
|
2019
Q4 | $4.58M | Sell |
54,400
-457
| -0.8% | -$36.9K | 0.02% | 780 |
|
|
2019
Q3 | $4.1M | Buy |
54,857
+974
| +2% | +$77.9K | 0.02% | 793 |
|
|
2019
Q2 | $3.41M | Buy |
53,883
+6,953
| +15% | +$352K | 0.01% | 853 |
|
|
2019
Q1 | $2.26M | Sell |
46,930
-1,522
| -3% | -$73.2K | 0.01% | 959 |
|
|
2018
Q4 | $1.62M | Sell |
48,452
-373
| -0.8% | -$13.6K | 0.01% | 1040 |
|
|
2018
Q3 | $2.56M | Buy |
48,825
+2,018
| +4% | +$80.3K | 0.01% | 957 |
|
|
2018
Q2 | $1.47M | Buy |
46,807
+9,378
| +25% | +$261K | 0.01% | 1156 |
|
|
2018
Q1 | $816K | Sell |
37,429
-1,477
| -4% | -$31.8K | ﹤0.01% | 1390 |
|
|
2017
Q4 | $786K | Buy |
38,906
+184
| +0.5% | +$3.54K | ﹤0.01% | 1508 |
|
|
2017
Q3 | $769K | Buy |
38,722
+2,896
| +8% | +$56.9K | ﹤0.01% | 1508 |
|
|
2017
Q2 | $620K | Buy |
35,826
+4,635
| +15% | +$59.8K | ﹤0.01% | 1558 |
|
|
2017
Q1 | $253K | Buy |
31,191
+2,065
| +7% | +$14.9K | ﹤0.01% | 2033 |
|
|
2016
Q4 | $229K | Sell |
29,126
-76
| -0.3% | -$611 | ﹤0.01% | 2097 |
|
|
2016
Q3 | $249K | Buy |
29,202
+44
| +0.2% | +$401 | ﹤0.01% | 2023 |
|
|
2016
Q2 | $340K | Buy |
29,158
+24,268
| +496% | +$304K | ﹤0.01% | 1798 |
|
|
2016
Q1 | $71K | Buy |
+4,890
| New | +$70.2K | ﹤0.01% | 3661 |
|
Other funds holding NVCR
American International Group's NVCR Position: Q2 2024 in Review
American International Group sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 1,750 shares — an estimated $27.4K sold.
American International Group first reported a position in NVCR in Q1 2016 and held it in 33 quarters. The position peaked at $4.58M in Q4 2019. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.
- American International Group reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
- American International Group sold 1,750 NovoCure shares in Q2 2024, an estimated $27.4K.
- American International Group first reported a position in NovoCure in Q1 2016 and held it in 33 quarters.
- American International Group's NovoCure position peaked at $4.58M in Q4 2019.
- 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.